NPPA fixes the prices in relation to the formulation of specific manufactures and marketing company

May 16, 2019 | by Avantis RegTech Legal Research Team

The National Pharmaceutical Pricing Authority (NPPA) on May 02, 2019, has passed an Order to fix the retail price of tablets, exclusive of goods and service tax, in relation to the formulation or brand name of manufactures and marketing company. 

The names of the tablet in relation to formulation:

i.Losartan + Chlorthalidone + Amlodipine Tablet (TRILOSAR 6.25 ) 

ii.Losartan + Chlorthalidone + Amlodipine Tablet (TRILOSAR 12.50)



Related Updates

Alternate Text

Get updates on the go on RuleZbook Mobile App.